Cub Pharmacy #1935/764 Durable Medical Equipment & Medical Supplies Location: 2197 Hudson Rd, St Paul, Minnesota 55119 Phone: (651) 501-4934 |
Allina Health Home Oxygen & Medical Durable Medical Equipment & Medical Supplies Location: 225 Smith Ave N, St Paul, Minnesota 55102 Phone: (651) 241-8469 |
Westlake Orthotics And Prosthetics Prosthetic/Orthotic Supplier Location: 360 Sherman St, St Paul, Minnesota 55102 Phone: (651) 291-9000 |
Visionworks Eyewear Supplier (Equipment, not the service) Location: 1201 Robert St S, St Paul, Minnesota 55118 Phone: (651) 451-7232 |
News Archive
Checkpoint Surgical, Inc., a U.S.-based medical device company with proprietary neurostimulation technology for nerve protection and repair, announced the publication of the first peer-reviewed study comparing the use of its Checkpoint Nerve Stimulator/Locator to Medtronic's Nerve Integrity Monitor for neural monitoring during thyroid and parathyroid surgeries in the April 2019 edition of The Laryngoscope.
According to a new survey distributed by The North American Menopause Society (NAMS), while 98 percent of women who participated consider bone strength to be an important health concern, nearly half (45 percent) of these women reported that osteoporosis was not addressed during their last routine OB/GYN visit, and more than a quarter (26.4 percent) of women surveyed have never discussed osteoporosis with their OB/GYN.
Diffusion Pharmaceuticals LLC today announced positive results of its Phase I/II proof-of-concept study of Trans Sodium Crocetinate (TSC) in patients suffering from walking impairment due to peripheral artery disease (PAD).
Inovio Pharmaceuticals, Inc. announced it has initiated a phase I trial of its hTERT DNA immunotherapy (INO-1400) alone or in combination with Inovio's IL-12 immune activator (INO-9012) in adults with breast, lung, or pancreatic cancer at high risk of relapse after surgery and other cancer treatments.
The Cancer Research Institute, a nonprofit organization dedicated to the development of immune system-based treatments for cancer, announced today its celebration of a significant new breakthrough in the treatment of melanoma, the deadliest form of skin cancer. The new treatment, a cancer immunotherapy created by Cancer Research Institute Scientific Advisory Council Associate Director James P. Allison, Ph.D., is designed to "take the brakes off the immune system," and is the first treatment ever proven to extend life for patients whose melanomas are unresponsive to existing cancer therapies.
› Verified 4 days ago